Home » Market Research » Buy Recommendations » Bristol-Myers Squibb Company
Balfour Capital Group Researched Bristol-Myers Squibb Co on July 24th, 2023.
Bristol-Myers Squibb Co is a pharmaceutical leader, delivering innovative treatments in oncology, immunology, cardiovascular, and other therapeutic areas, driving advancements in healthcare worldwide.